Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. (Q40722578)

23 September 2017

title

Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. (English)

1 reference

23 September 2017

0 references

multiple drug resistance

1 reference

Petra Kowalski

1

1 reference

23 September 2017

Ulrike Stein

series ordinal

2

1 reference

23 September 2017

George L Scheffer

series ordinal

3

1 reference

23 September 2017

Hermann Lage

series ordinal

4

1 reference

23 September 2017

publication date

1 July 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

9

1 reference

23 September 2017

issue

7

1 reference

23 September 2017

page(s)

579-586

1 reference

Multidrug resistance in cancer: role of ATP-dependent transporters

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Effect of the breast-cancer resistance protein on atypical multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Sequence requirements of the hammerhead RNA self-cleavage reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Selection and characterization of a high-activity ribozyme directed against the antineoplastic drug resistance-associated ABC transporter BCRP/MXR/ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Selection of a high activity ribozyme against cytostatic drug resistance-associated glypican-3 using an in vitro assay containing total tumor RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Kinetic characterization of ribozymes directed against the cisplatin resistance-associated ABC transporter cMOAT/MRP2/ABCC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Involvement of the DNA mismatch repair system in antineoplastic drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Numbering system for the hammerhead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700471

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700471

1 reference

Dimensions Publication ID

23 September 2017

1021204126

0 references

1 reference